Literature DB >> 6275978

Intraductal carcinoma of the breast: follow-up after biopsy only.

D L Page, W D Dupont, L W Rogers, M Landenberger.   

Abstract

Twenty-eight women with ductal carcinoma in situ (DCIS) of the breast treated by biopsy only were identified in a histologic review of 11,760 biopsies performed between 1950 and 1968. Seven of the 25 women followed for more than three years developed invasive breast carcinoma, all in the same breast with a previously detected DCIS. Average follow-up interval for the 18 women not developing invasive carcinoma was 16 years. The invasive carcinomas presented clinically from three to ten years (average, 6.1) after the biopsies demonstrating DCIS. Four women with invasive carcinoma developed distant metastases following mastectomy. This study suggests that 28% of women treated with biopsy only for DCIS presenting as an incidental histologic finding will develop invasive carcinoma in a follow-up period of approximately 15 years.

Entities:  

Mesh:

Year:  1982        PMID: 6275978     DOI: 10.1002/1097-0142(19820215)49:4<751::aid-cncr2820490426>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  103 in total

1.  The biology of incipient, pre-invasive or intraepithelial neoplasia.

Authors:  William E Grizzle; Sudhir Srivastava; Upender Manne
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  Loss of heterozygosity in lobular carcinoma in situ of the breast.

Authors:  S R Lakhani; N Collins; J P Sloane; M R Stratton
Journal:  Clin Mol Pathol       Date:  1995-04

3.  Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.

Authors:  Kalliopi P Siziopikou; Stewart J Anderson; Melody A Cobleigh; Thomas B Julian; Douglas W Arthur; Ping Zheng; Eleftherios P Mamounas; Eduardo R Pajon; Robert J Behrens; Janice F Eakle; Nick C Leasure; James N Atkins; Jonathan A Polikoff; Thomas E Seay; Worta J McCaskill-Stevens; Rachel Rabinovitch; Joseph P Costantino; Norman Wolmark
Journal:  Breast Cancer Res Treat       Date:  2013-11-08       Impact factor: 4.872

Review 4.  Management of ductal carcinoma in situ of the breast.

Authors:  N J Carty; C Carter; G T Royle; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

5.  Natural history of in situ breast cancer in a defined population.

Authors:  W J Temple; M Jenkins; F Alexander; W S Hwang; L H Marx; A W Lees; H T Williams; M G Pambrun
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

6.  Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis.

Authors:  I Kong; S A Narod; C Taylor; L Paszat; R Saskin; S Nofech-Moses; D Thiruchelvam; W Hanna; J P Pignol; S Sengupta; L Elavathil; P A Jani; S J Done; S Metcalfe; E Rakovitch
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

7.  Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.

Authors:  Jin You Kim; Jin Joo Kim; Ji Won Lee; Nam Kyung Lee; Geewon Lee; Taewoo Kang; Heesung Park; Yo Han Son; Robert Grimm
Journal:  Eur Radiol       Date:  2018-08-02       Impact factor: 5.315

8.  Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.

Authors:  Jennifer A Ligibel; Ann Partridge; Anita Giobbie-Hurder; Mehra Golshan; Karen Emmons; Eric P Winer
Journal:  Ann Surg Oncol       Date:  2008-10-24       Impact factor: 5.344

Review 9.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

Review 10.  Evaluation and management of high risk and premalignant lesions of the breast.

Authors:  D L Page; R A Jensen
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.